SEARCH

SEARCH BY CITATION

References

  • Bence N. F., Sampat R. M. and Kopito R. R. (2001) Impairment of the ubiquitin–proteasome system by protein aggregation. Science 292, 15521155.
  • Bruening W., Roy J., Giasson B., Figlewicz D. A., Mushynski W. E. and Durham H. D. (1999) Up-regulation of protein chaperones preserves viability of cells expressing toxic Cu/Zn-superoxide dismutase mutants associated with amyotrophic lateral sclerosis. J.Neurochem. 72, 693699.DOI: 10.1046/j.1471-4159.1999.0720693.x
  • Bruijn L. I., Houseweart M. K., Kato S., Anderson K. L., Anderson S.D., Ohama E., Reaume A. G., Scott R. W. and Cleveland D. W. (1998) Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type SOD1. Science 281, 18511854.
  • Carmichael J., Chatellier J., Woolfson A., Milstein C., Fersht A. R. and Rubinsztein D. C. (2000) Bacterial and yeast chaperones reduce both aggregate formation and cell death in mammalian cell models of Huntington's disease. Proc. Natl Acad. Sci. USA 97, 97019705.
  • Chai Y., Koppenhafer S. L., Shoesmith S. J., Perez M. K. and Paulson H.L. (1999) Evidence for proteasome involvement in polyglutamine disease: localization to nuclear inclusions in SCA3/MJD and suppression of polyglutamine aggregation in vitro. Hum. Mol. Genet. 8, 673682.
  • Chen M. and Fernandez H. L. (1999) The Alzheimer's plaques, tangles and memory deficits may have a common origin. Part V: why is Ca2+ signal lower in the disease? Front Biosci. 4, A9A15.
  • Chen S., Bethelier V., Yang W. and Wetzel R. (2001) Polyglutamine aggregation behavior in vitro supports a recruitment mechanism of cytotoxicity. J. Mol. Biol. 311, 173182.
  • Cleveland D. W. and Rothstein J. D. (2001) From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS. Nat Rev. Neurosci. 2, 806819.
  • Cudkowicz M. E., McKenna-Yasek D., Sapp P. E., Chin W., Geller B., Hayden D. L., Schoenfeld D. A., Hosler B. A., Horvitz H. R. and Brown R. H. (1997) Epidemiology of mutations in superoxide dismutase in amyotrophic lateral sclerosis. Ann. Neurol. 41, 210221.
  • Cummings C. J., Reinstein E., Sun Y., Antalffy B., Jiang Y., Ciechanover A., Orr H. T., Beaudet A. L. and Zoghbi H. Y. (1999) Mutation of the E6-AP ubiquitin ligase reduces nuclear inclusion frequency while accelerating polyglutamine-induced pathology in SCA1 mice. Neuron 24, 879892.
  • Ghadge G. D., Lee J. P., Bindokas V. P., Jordan J., Ma L., Miller R. J. and Roos R. P. (1997) Mutant superoxide dismutase-1-linked familial amyotrophic lateral sclerosis: molecular mechanisms of neuronal death and protection. J. Neurosci. 17, 87568766.
  • Helekar S. A. and Patrick J. (1997) Peptidyl prolyl cis-trans isomerase activity of cyclophilin A in functional homo-oligomeric receptor expression. Proc. Natl Acad. Sci. USA 94, 54325437.
  • Jana N. R., Zemskov E. A., Wang G. and Nukina N. (2001) Altered proteasomal function due to the expression of polyglutamine-expanded truncated N-terminal huntingtin induces apoptosis by caspase activation through mitochondrial cytochrome c release. Hum. Mol. Genet. 10, 10491059.
  • Johnston J. A., Dalton M. J., Gurney M. E. and Kopito R. R. (2000) Formation of high molecular weight complexes of mutant Cu, Zn-superoxide dismutase in a mouse model for familial amyotrophic lateral sclerosis. Proc. Natl Acad. Sci. USA 97, 1257112576.
  • Kim S. Y., Kwon O. J. and Park J. W. (2001) Inactivation of catalase and superoxide dismutase by singlet oxygen derived from photoactivated dye. Biochimie 83, 437444.
  • Kuemmerle S., Gutekunst C. A., Klein A. M., Li X. J., Li S. H., Beal M.F., Hersch S. M. and Ferrante R. J. (1999) Huntington aggregates may not predict neuronal death in Huntington's disease. Ann. Neurol. 46, 842849.DOI: 10.1002/1531-8249(199912)46:6<842::AID-ANA6>3.0.CO;2-O
  • Lee J., Palfrey H., Bindokas V., Ghadge G., Ma L., Miller R. and Roos R. (1999) The role of immunophilins in mutant superoxide dismutase-1 linked familial amyotrophic lateral sclerosis. Proc. Natl Acad. Sci. USA 96, 32513256.
  • Lee M. H., Hyun D. H., Jenner P. and Halliwell B. (2001) Effect of proteasome inhibition on cellular oxidative damage, antioxidant defences and nitric oxide production. J. Neurochem. 78, 3241.
  • Patel Y. M. and Lane M. D. (1999) Role of calpain in adipocyte differentiation. Proc. Natl Acad. Sci. USA 96, 12791284.
  • Saudou F., Finkbeiner S., Devys D. and Greenberg M. E. (1998) Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions. Cell 95, 5566.
  • Shinder G., Lacourse M.-C., Minotti S. and Durham H. D. (2001) Mutant Cu/Zn-Superoxide dismutase proteins have altered solubility and interact with heat shock/stress proteins in models of amyotrophic lateral sclerosis. J. Biol. Chem. 276, 1279112796.
  • Telford W. G., King L. E. and Fraker P. J. (1992) Comparative evaluation of several DNA binding dyes in the detection of apoptosis-associated chromatin degradation by flow cytometry. Cytometry 13, 137143.
  • Ward C., Liu J., Young D. and Cleveland D. W. (2001) Increasing the protein folding chaperone HSP70 does not affect timecourse of SOD-1 mutant-mediated amyotrophic lateral sclerosis. Soc. Neurosci. Abstr. 27, 572.14.
  • Watanabe M., Dykes-Hoberg M., Cizewski Culotta V., Price D. L., Wong P. C. and Rothstein J. D. (2001) Histological evidence of protein aggregation in mutant SOD1 transgenic mice and in amyotrophic lateral sclerosis neural tissues. Neurobiol. Dis. 8, 933941.DOI: 10.1006/nbdi.2001.0443
  • Wyttenbach A., Swartz J., Kita H., Thykjaer T., Carmichael J., Bradley J., Brown R., Maxwell M., Schapira A., Orntoft T. F., Kato K. and Rubinsztein D. C. (2001) Polyglutamine expansions cause decreased CRE-mediated transcription and early gene expression changes prior to cell death in an inducible cell model of Huntington's disease. Hum. Mol. Genet. 10, 18291845.
  • Zhou H., Li S. H. and Li X. J. (2001) Chaperone suppression of cellular toxicity of huntingtin is independent of polyglutamine aggregation. J. Biol. Chem. 276, 4841748424.